Andrey Zarur, GreenLight Biosciences CEO
June 1, 2023 12:28 PM EDT
R&D
Manufacturing

Green­Light Bio­sciences se­cures merg­er as it looks to go pri­vate

Tyler Patchen

News Reporter

Green­Light Bio­science, the de­vel­op­er and man­u­fac­tur­er of RNA vac­cines and ther­a­peu­tics, is set to be ac­quired.

The com­pa­ny an­nounced ear­li­er this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times